Trial intelligence / Profile preview

Atenolol vs losartan in individuals with Marfan syndrome

2006-003991-37Phase 4Completed

Sponsor
Ghent University Hospital
Start
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Marfan syndrome (MFS) comparing Atenolol arm with Losartan arm (2 arms). Primary endpoint: Rate of change in aortic root (sinuses of Valsalva) BSA-adjusted Z-score. Started Dec 2006; status: completed.

02

Drugs

atenolollosartan
03

Conditions

Marfan syndrome (MFS)

Beyond the preview

Go deeper on 2006-003991-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003991-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call